Lupus drug trial aims for remission without daily pills
NCT ID NCT07598396
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study tests a drug called mosunetuzumab in 30 people with lupus, a disease where the immune system attacks the body. The goal is to see if the drug can put lupus into remission so that participants can stop most lupus medications for at least 6 months. However, some people may still need low-dose steroids or other treatments long-term, so this is not a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili)
RECRUITINGBrescia, Lombardy, 25123, Italy
-
Centro de Investigacion en Reumatologia y Especialdades Medicas SAS. CIREEM
RECRUITINGBogotá, 110221, Colombia
-
Clinica de la Costa S.A.S
RECRUITINGBarranquilla, 080020, Colombia
-
Clinical Trials Network Helderberg
RECRUITINGSomerset West, Western Cape, 7130, South Africa
-
Clnica SER da Bahia
RECRUITINGSalvador, Estado de Bahia, 40150-150, Brazil
-
Complexo Hospitalar de Niteroi
RECRUITINGNiterói, Rio de Janeiro, 24030-103, Brazil
-
Emmed Research
RECRUITINGPretoria, Gauteng, 0002, South Africa
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITINGRome, Lazio, 00168, Italy
-
Hospital Pablo Tobon Uribe
RECRUITINGMedellín, 050034, Colombia
-
Hospital das Clinicas de Ribeirao Preto
RECRUITINGRibeiro Preto, São Paulo, 14048-900, Brazil
-
Hospital das Clnicas da Faculdade de Medicina da USP
RECRUITINGSão Paulo, São Paulo, 05403-000, Brazil
-
IPC MT Instituto de Pesquisas Clinicas do Mato Grosso
RECRUITINGCuiab, Mato Grosso, 78020-500, Brazil
-
L2IP ?Instituto de Pesquisas Clínicas Ltda.
RECRUITINGBrasília, Federal District, 70200-730, Brazil
-
LMK Servios Mdicos S/S Ltda
RECRUITINGPorto Alegre, Rio Grande do Sul, 90480-000, Brazil
-
University of Cape Town Kidney and Hypertension Research Unit
RECRUITINGCape Town, Western Cape, 7925, South Africa
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app bridge the lupus care gap for women of color?
- Can a single drug calm lupus kidney disease without a cocktail of meds?
- Blood traps may reveal lupus kidney treatment success
- Can a peer coach help young people take control of their chronic illness?
- Lupus patients may get a boost from doctors checking their prescription refill records
- Engineered immune cells take aim at Hard-to-Treat autoimmune diseases